Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition –An Outstanding Challenge
Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
Attila Fintha1, Ákos Gasparics2, László Rosivall3 and Attila Sebe3,4*
12nd Department of Pathology, Semmelweis University, Budapest, Hungary
21st Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary
3Department of Pathophysiology, International Nephrology Research and Training Center, Semmelweis University, Budapest, Hungary
4Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany
Back in 1995, a landmark paper was published, which shaped the fibrosis literature for many years to come. During the characterization of a fibroblast-specific marker (FSP1) in the kidneys, an observation was made, which gave rise to the hypothesis that “fibroblasts in some cases arise from the local conversion of epithelium.” In the following years, epithelial-mesenchymal transition was in the spotlight of fibrosis research, especially in the kidney. However, the hypothesis came under scrutiny following some discouraging findings from lineage tracing experiments and clinical observations. In this review, we provide a timely overview of the current position of the epithelial-mesenchymal transition hypothesis in the context of fibrosis (with a certain focus on renal fibrosis) and highlight some of the potential hurdles and pitfalls preventing therapeutic breakthroughs targeting fibrotic epithelial...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Autoimmune Disease | Avapro | Biotechnology | Bone Marrow Aspiration and Biopsy | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemistry | Chronic Kidney Disease | Cirrhosis | Cleft Palate | Clinical Trials | Cozaar | Dermatology | Diabetes | Diabetes Type 2 | Diabetic Ulcers | Drugs & Pharmacology | Endocrinology | Environmental Health | Epidemics | Epidemiology | Epithelial Cancer | Finland Health | Gastroschisis Repair | Genetics | Germany Health | Glomerulonephritis | Heart | Hepatitis | Hepatitis B | Hungary Health | Hypertension | Interstitial Lung Disease | Liver | Losartan | Men | Molecular Biology | Nephrectomy | Nephrotic Syndrome | Neurology | Neuroscience | OBGYN | Pathology | Polycystic Kidney Disease | Proteinuria | Rheumatology | Scleroderma | Skin | Skin Biopsy | Skin Graft | Stem Cell Therapy | Stem Cells | Study | Tetracycline | Thyroid | Thyroid Cancer | Toxicology | Training | Translocation | Universities & Medical Training | Ureter and Renal Pelvis Cancer | Urology & Nephrology